Trial intelligence / Profile preview

PEAChY-O trial of oral olanzapine versus oral diazepam for paediatric acute severe behavioural disturbance

ACTRN12621001236886Phase 3Completed

Sponsor
Murdoch Children's Research Institute
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in acute severe behavioural disturbance (ASBD) comparing Olanzapine with Diazepam (2 arms). Primary endpoint: Successful sedation without additional sedation at 1 hour. Started Oct 2021; status: completed.

02

Drugs

olanzapinediazepam
03

Conditions

acute severe behavioural disturbance (ASBD)

Beyond the preview

Go deeper on ACTRN12621001236886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12621001236886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call